ARSENAULT KAITLYN (Chief Financial Officer) received a stock award from SKYE BIOSCIENCE, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/1/2024ACC: 0001516551-24-000012
Officer· Chief Financial Officer
Since Oct 2021
+100K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
13.5%
2/29/2024
185.74K→210.74K
Total
Net shares
+25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/29/2024 | A · Award | +25K | — | — | 13.5% | 185.74K | 210.74K |
| Total | +25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
75K shares
Shares
+75K
Strike price
14.56
Held after
75K
Exercisable
—
2/29/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock75K shares | 2/29/2024 | A · Award | +75K | 14.56 | — | 75K |